Peritoneal Dialysis Market Size, Share, Growth, And Industry Analysis By Type (Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and Others) By Application (CAPD, APD and Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

PERITONEAL DIALYSIS MARKET OVERVIEW

The global Peritoneal Dialysis Market is estimated to be valued at approximately USD 0.14 Billion in 2026. The market is projected to reach USD 0.2 Billion by 2035, expanding at a CAGR of 6.1% from 2026 to 2035.

The Peritoneal Dialysis Market is a critical segment of renal replacement therapy within the global healthcare industry, supporting treatment for more than 4 million patients diagnosed with end-stage renal disease (ESRD) worldwide. Approximately 11–13% of global dialysis patients use peritoneal dialysis therapy as an alternative to hemodialysis. According to Peritoneal Dialysis Market Analysis and Peritoneal Dialysis Market Research Report insights, nearly 380,000 patients globally rely on continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD). Around 68% of peritoneal dialysis treatments are performed in home settings, reducing hospital dependency. The Peritoneal Dialysis Market Size is supported by more than 70 countries offering structured home dialysis programs, while approximately 55% of dialysis centers provide patient training programs for peritoneal dialysis therapy adoption.

The USA Peritoneal Dialysis Market represents one of the largest regional segments within the global Peritoneal Dialysis Industry Report landscape. The United States has nearly 800,000 patients living with kidney failure, and approximately 14% of dialysis patients currently use peritoneal dialysis treatment. Nearly 110,000 patients receive peritoneal dialysis therapy in home-based settings across the country. More than 7,500 dialysis centers operate nationwide, with around 2,300 facilities offering dedicated peritoneal dialysis training programs. According to Peritoneal Dialysis Market Insights and Peritoneal Dialysis Market Forecast evaluations, approximately 48% of new dialysis patients in the U.S. receive education about home-based dialysis options during the first 90 days of treatment.

KEY FINDINGS

Latest Trends

Market Demand To Increase Due To The Growing Adoption Of APD

The Peritoneal Dialysis Market Trends indicate increasing adoption of home-based dialysis therapies as healthcare systems focus on reducing hospital admissions and treatment costs. Nearly 68% of peritoneal dialysis patients globally perform dialysis procedures at home, reducing dependency on hospital-based dialysis units. Automated peritoneal dialysis systems are gaining popularity, with approximately 35% of patients using APD devices capable of performing dialysis cycles overnight during 8–10 hour treatment periods.

Technological innovation is shaping the Peritoneal Dialysis Market Growth landscape. Approximately 44% of newly installed peritoneal dialysis machines include digital monitoring features that track treatment parameters such as fluid exchange volume, dwell time, and ultrafiltration rates. According to Peritoneal Dialysis Market Insights, nearly 29% of dialysis centers are implementing remote monitoring platforms allowing clinicians to review patient dialysis data in real time.

Another important trend in the Peritoneal Dialysis Market Outlook is the development of improved dialysis solutions. Nearly 38% of dialysis solution manufacturers are introducing low-glucose degradation formulations designed to reduce peritoneal membrane damage during long-term therapy. Additionally, approximately 26% of medical device manufacturers are developing portable dialysis cyclers weighing less than 15 kilograms, improving mobility for home dialysis patients.

• According to the U.S. Centers for Disease Control and Prevention (CDC), about 15% of U.S. adults—37 million people—have chronic kidney disease, driving higher adoption of automated peritoneal dialysis (APD).

• The European Renal Association (ERA) reported that nearly 25% of dialysis patients in Europe are shifting to home-based dialysis, boosting demand for peritoneal dialysis devices.

Download Free Sample to learn more about this report

PERITONEAL DIALYSIS MARKET SEGMENTATION

The Peritoneal Dialysis Market Size is segmented by product type and application based on treatment method. Product segmentation includes dialysis machines, dialysis solutions, and supporting consumables such as catheters and tubing systems. Dialysis solutions represent the largest segment due to their daily usage during treatment cycles. Application segmentation includes continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). CAPD remains widely used due to its simplicity and lower equipment requirements, while APD adoption is increasing due to improved convenience and overnight treatment capabilities. According to Peritoneal Dialysis Market Analysis, nearly 57% of global peritoneal dialysis patients use CAPD, while approximately 35% use APD systems.

By Type

According to type, the market can be segmented into Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and others. The peritoneal dialysis machine is holds the majority of the market share by type segment.

• Peritoneal Dialysis Machine: Peritoneal dialysis machines account for approximately 31% of the Peritoneal Dialysis Market Share. These machines, commonly referred to as automated dialysis cyclers, allow patients to perform dialysis treatments during sleep cycles lasting 8–10 hours. Approximately 35% of global peritoneal dialysis patients currently use automated machines. Nearly 42% of newly diagnosed dialysis patients choosing home therapy prefer APD systems because they reduce the need for manual fluid exchanges during daytime hours. Modern dialysis cyclers can perform up to 6 fluid exchanges per night, improving toxin removal efficiency. Additionally, approximately 28% of dialysis machines installed globally include digital connectivity features that transmit treatment data to healthcare providers.

• Peritoneal Dialysis Solution: Peritoneal dialysis solutions represent nearly 49% of the Peritoneal Dialysis Market Size, making them the most widely used consumable in dialysis therapy. Each dialysis treatment requires approximately 2–3 liters of dialysis fluid per exchange, and CAPD therapy typically involves 4 exchanges per day. As a result, a single patient may use more than 10 liters of dialysis solution daily. Approximately 72% of dialysis solutions are glucose-based formulations designed to facilitate fluid removal and toxin filtration. Nearly 33% of manufacturers are developing low-glucose degradation solutions to reduce long-term damage to the peritoneal membrane.

• Others: Other products represent approximately 20% of the Peritoneal Dialysis Market Share, including catheters, transfer sets, tubing systems, and disinfectants. Nearly 85% of peritoneal dialysis procedures require specialized silicone catheters implanted in the abdominal cavity to facilitate fluid exchange. Approximately 38% of dialysis accessories include sterile tubing systems designed to reduce infection risk during treatment. Nearly 27% of dialysis clinics use disposable transfer sets for each treatment cycle to maintain hygiene standards. Additionally, approximately 19% of dialysis consumables are designed specifically for pediatric dialysis patients requiring lower fluid volumes.

By Application

Based on application, the market can be divided into CAPD, APD and others. By the application segment, the CAPD holds the largest market share.

• CAPD (Continuous Ambulatory Peritoneal Dialysis): CAPD represents approximately 57% of the Peritoneal Dialysis Market Share. This treatment method requires patients to perform manual dialysis fluid exchanges 4 times per day, each exchange lasting approximately 30–40 minutes. Nearly 215,000 patients worldwide currently use CAPD therapy. Approximately 46% of CAPD patients are over the age of 60, reflecting the accessibility of this treatment method without advanced medical equipment. Additionally, nearly 63% of CAPD treatments are performed in home environments, reducing hospital dependency for long-term renal therapy. Around 28% of dialysis training centers prioritize CAPD education programs because the technique requires limited technical equipment compared to automated dialysis systems.

• APD (Automated Peritoneal Dialysis): APD accounts for approximately 35% of the Peritoneal Dialysis Market Size. These systems use automated machines to perform dialysis cycles during nighttime treatment sessions. Approximately 130,000 patients globally use APD systems. Modern APD machines can perform up to 8 automated fluid exchanges during overnight treatment cycles. Nearly 41% of younger dialysis patients under age 50 prefer APD therapy due to greater daytime mobility. Around 32% of new dialysis machine installations globally are APD cyclers designed for home-based renal care. Additionally, nearly 26% of dialysis clinics report increased patient adherence with APD due to reduced daytime treatment interruptions.

• Others: Other dialysis methods represent nearly 8% of the Peritoneal Dialysis Market Share, including intermittent peritoneal dialysis performed in hospital settings. Approximately 18% of pediatric dialysis patients use modified dialysis schedules adapted to smaller fluid exchange volumes. Nearly 14% of emergency dialysis treatments in rural healthcare facilities utilize intermittent peritoneal dialysis due to limited hemodialysis infrastructure. Approximately 11% of temporary dialysis procedures in intensive care units rely on intermittent peritoneal dialysis when vascular access is limited. Additionally, nearly 9% of acute kidney injury treatments in developing healthcare systems involve short-term peritoneal dialysis therapy.

MARKET DYNAMICS

Driving Factor

Rising prevalence of chronic kidney disease and diabetes

The primary driver influencing the Peritoneal Dialysis Market Growth is the increasing prevalence of chronic kidney disease (CKD). Globally, more than 850 million people are estimated to suffer from kidney-related disorders, and approximately 10% of the global population shows signs of chronic kidney disease. Nearly 2 million patients annually progress to end-stage renal disease requiring dialysis or kidney transplantation. Diabetes contributes to approximately 38% of kidney failure cases, while hypertension accounts for nearly 26%. According to Peritoneal Dialysis Market Analysis, nearly 48% of new dialysis patients in developed healthcare systems are offered home dialysis therapy as a cost-effective treatment alternative.

• According to the World Health Organization (WHO), end-stage renal disease affects over 2 million people worldwide, with peritoneal dialysis being a critical treatment alternative.

• The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) highlighted that 1 in 7 adults in the U.S. suffers from kidney disease, significantly increasing the need for dialysis.

Restraining Factor

Infection risks and catheter complications

Despite strong adoption trends, infection risks remain a significant restraint in the Peritoneal Dialysis Market. Peritonitis is one of the most common complications associated with peritoneal dialysis treatment, affecting approximately 0.24 to 0.40 episodes per patient-year. Nearly 36% of dialysis patients experience at least one infection-related complication during the first 2 years of therapy. Catheter-related issues also affect approximately 18% of peritoneal dialysis patients, leading to treatment discontinuation or conversion to hemodialysis therapy. According to Peritoneal Dialysis Market Research Report evaluations, nearly 27% of healthcare providers report challenges in maintaining strict infection control protocols during home dialysis procedures.

• The International Society for Peritoneal Dialysis (ISPD) estimates that around 20–30% of peritoneal dialysis patients experience peritonitis annually, which restricts adoption.

• According to the Canadian Institute for Health Information (CIHI), hospital readmission rates for dialysis patients exceed 35%, reflecting complications that slow peritoneal dialysis acceptance.

Expansion of home dialysis programs and remote monitoring

Opportunity

Home dialysis expansion represents a major opportunity in the Peritoneal Dialysis Market Opportunities landscape. Nearly 68% of peritoneal dialysis patients perform treatment at home, reducing hospital treatment costs and improving patient lifestyle flexibility. Approximately 41% of healthcare systems in developed economies are promoting home dialysis programs as part of national kidney disease management strategies. Remote patient monitoring technologies are also expanding rapidly, with nearly 33% of dialysis centers implementing digital platforms that allow physicians to track dialysis parameters remotely. These technologies enable clinicians to monitor fluid balance, infection indicators, and treatment adherence for more than 20,000 patients in advanced dialysis networks.

Patient training and treatment adherence

Challenge

Patient training and adherence represent significant challenges within the Peritoneal Dialysis Market Industry Analysis. Peritoneal dialysis therapy requires extensive patient education, with training programs lasting between 5 and 7 days before patients can safely perform treatment at home. Approximately 22% of dialysis patients experience difficulties managing treatment schedules that require 4 fluid exchanges per day for CAPD therapy. According to Peritoneal Dialysis Market Insights, nearly 17% of patients discontinue peritoneal dialysis within the first 3 years due to lifestyle limitations or complications. Additionally, around 14% of healthcare providers report difficulties ensuring consistent treatment adherence among elderly dialysis patients above 65 years of age.

• Download Free Sample to learn more about this report

•  

PERITONEAL DIALYSIS MARKET REGIONAL INSIGHTS

North America Dominates The Market Due To The Presence Of Key Market Players

In North America, people suffering from chronic kidney disease have increased significantly due to the rising prevalence of diabetes and high blood pressure. Additionally, a growing percentage of kidney patients necessitate regular dialysis treatment. As a result, the peritoneal dialysis market is dominated by North America owing to the presence of key market players which include both governments and private parties who are investing considerably in the development of cutting-edge medical devices in the region.  After North America, the Asia Pacific region is estimated to be the second leading region over the forecast period because of the rising incidences of kidney failure and the growing geriatric population in the region.

• North America

North America dominates the Peritoneal Dialysis Market Share with approximately 39% of global peritoneal dialysis patients. The United States accounts for nearly 82% of regional dialysis treatment adoption, supported by advanced renal healthcare infrastructure and government reimbursement programs. Approximately 800,000 patients in the United States are diagnosed with kidney failure, and nearly 110,000 patients currently use peritoneal dialysis therapy. More than 7,500 dialysis centers operate across North America, and approximately 2,300 centers provide dedicated peritoneal dialysis training programs. According to Peritoneal Dialysis Market Analysis, nearly 48% of newly diagnosed dialysis patients receive counseling about home dialysis therapy options during the first 90 days of treatment.

Home dialysis adoption continues to increase in the region. Nearly 68% of peritoneal dialysis patients in North America perform dialysis procedures at home rather than in hospital facilities. Additionally, approximately 34% of dialysis clinics have introduced remote monitoring systems that allow physicians to track treatment parameters for more than 15,000 home dialysis patients. The Peritoneal Dialysis Market Insights also highlight strong technological adoption in North America. Nearly 41% of dialysis machines installed in the region include automated treatment monitoring systems capable of recording fluid exchange data and treatment cycle durations for up to 10 hours per session.

• Europe

Europe represents approximately 21% of the global Peritoneal Dialysis Market Size, with more than 85,000 patients receiving peritoneal dialysis therapy across regional healthcare systems. Countries such as Germany, France, the United Kingdom, and Italy collectively account for nearly 62% of regional dialysis treatment adoption. Nearly 45% of European dialysis centers provide structured training programs for patients beginning home dialysis therapy. According to Peritoneal Dialysis Market Research Report data, approximately 52% of dialysis patients in Europe are educated about peritoneal dialysis as a primary treatment option before initiating long-term dialysis therapy.

Automated peritoneal dialysis systems are increasingly adopted in the region. Nearly 38% of European peritoneal dialysis patients use APD machines capable of performing 6–8 automated fluid exchanges per night. Additionally, approximately 29% of hospitals have implemented digital patient monitoring platforms designed to track treatment outcomes and infection rates. The Peritoneal Dialysis Market Trends also indicate strong regulatory emphasis on infection prevention. Nearly 33% of European dialysis clinics use advanced sterile catheter insertion techniques that have reduced infection incidence rates by approximately 22% during the first 12 months of therapy.

• Asia-Pacific

Asia-Pacific accounts for approximately 31% of the global Peritoneal Dialysis Market Share, supported by a rapidly growing patient population and expanding healthcare infrastructure. Countries such as China, Japan, India, and South Korea collectively represent nearly 74% of regional dialysis patients. China alone accounts for nearly 120,000 peritoneal dialysis patients, making it one of the largest national markets in the Peritoneal Dialysis Industry Analysis landscape. Nearly 1,200 hospitals in China provide specialized peritoneal dialysis treatment programs.

India also represents a growing segment of the Peritoneal Dialysis Market Growth environment. Approximately 175,000 patients in India currently require dialysis therapy, and nearly 14% of them receive peritoneal dialysis treatment. Around 36% of tertiary hospitals in the country provide training programs that allow patients to perform dialysis procedures at home. The Peritoneal Dialysis Market Outlook for Asia-Pacific also highlights increasing investment in dialysis technology. Nearly 27% of hospitals in the region have installed automated dialysis cyclers capable of performing up to 8 treatment cycles per night. Additionally, approximately 22% of dialysis clinics are implementing remote monitoring platforms to track treatment adherence for more than 12,000 home dialysis patients.

• Middle East & Africa

The Middle East & Africa region represents approximately 9% of the global Peritoneal Dialysis Market Size, with increasing dialysis infrastructure development across countries such as Saudi Arabia, South Africa, and the United Arab Emirates. Approximately 35,000 patients in the region receive dialysis therapy annually, and nearly 12% of them rely on peritoneal dialysis treatment. Nearly 41% of dialysis centers in the Middle East offer peritoneal dialysis training programs designed to support home treatment adoption.

Saudi Arabia accounts for nearly 28% of regional dialysis patients, supported by government-funded renal care programs that provide treatment access for more than 9,000 dialysis patients annually. Additionally, approximately 31% of hospitals in the Gulf Cooperation Council countries have implemented automated dialysis systems capable of performing 6–7 dialysis cycles per night. In Africa, dialysis infrastructure expansion continues to influence the Peritoneal Dialysis Market Opportunities landscape. Nearly 22% of dialysis clinics in South Africa now offer peritoneal dialysis therapy as an alternative to in-center hemodialysis treatment. Additionally, approximately 17% of hospitals across the region are introducing telehealth monitoring platforms designed to track dialysis treatment adherence for rural patient populations.

List Of Top Peritoneal Dialysis Companies

• Baxter (U.S.)
• Fresenius (Germany)
• B. Braun (Germany)
• Terumo (Japan)
• Huaren (China)
• CR Double-Crane (China)
• Qingshan Likang (China)
• Tj Tianan (U.S.)
• Renax (U.S.)
• Medionics (Canada)
• Bluesail (China)

Top Two Companies with Highest Market Share

• Baxter – Holds approximately 34% of the global Peritoneal Dialysis Market Share, supplying dialysis solutions and automated dialysis machines to more than 100 countries and supporting treatment for nearly 150,000 peritoneal dialysis patients worldwide.

• Fresenius – Accounts for nearly 29% of the Peritoneal Dialysis Market Share, operating more than 4,000 dialysis clinics globally and manufacturing dialysis equipment used by approximately 120,000 patients receiving peritoneal dialysis therapy.

Investment Analysis and Opportunities

The Peritoneal Dialysis Market Opportunities continue to expand as healthcare systems invest heavily in home dialysis infrastructure and renal care technologies. Nearly 41% of healthcare providers globally are allocating funds toward expanding home dialysis training programs designed to support patient independence. These initiatives aim to reduce hospital dialysis demand by nearly 25% over the next decade. Technological investment is also accelerating across the Peritoneal Dialysis Market Growth landscape. Approximately 36% of dialysis equipment manufacturers are developing advanced automated dialysis cyclers capable of performing up to 8 fluid exchange cycles per night. These machines also include digital monitoring systems capable of transmitting treatment data to healthcare providers through remote connectivity platforms.

Healthcare infrastructure investment is another important growth driver. Nearly 33% of hospitals worldwide are expanding renal care departments to accommodate rising dialysis patient populations. According to Peritoneal Dialysis Market Analysis, more than 20,000 new dialysis training programs have been introduced globally over the past 5 years. Pharmaceutical and medical device companies are also investing in improved dialysis solutions. Nearly 29% of dialysis solution manufacturers are developing low-glucose formulations designed to reduce long-term damage to the peritoneal membrane. Additionally, approximately 24% of healthcare systems are supporting research programs focused on wearable dialysis technologies capable of providing continuous toxin removal.

New Product Development

Innovation in the Peritoneal Dialysis Market Trends is focused on improving treatment safety, efficiency, and patient convenience. Nearly 42% of dialysis equipment manufacturers are developing next-generation automated peritoneal dialysis machines equipped with digital monitoring systems that track treatment cycles lasting between 8 and 10 hours. Portable dialysis devices represent another area of product innovation. Approximately 31% of medical device companies are developing compact dialysis cyclers weighing less than 15 kilograms, enabling patients to travel while continuing treatment. These devices can perform up to 6 automated dialysis exchanges per night.

Dialysis solution development is also evolving rapidly within the Peritoneal Dialysis Market Outlook. Nearly 37% of manufacturers are introducing biocompatible dialysis solutions that reduce inflammation in the peritoneal membrane during long-term treatment. Additionally, approximately 26% of research programs are focused on amino acid-based dialysis solutions designed to improve nutritional support for dialysis patients. Digital healthcare integration is another major innovation trend. Nearly 23% of dialysis clinics have adopted cloud-based dialysis management systems capable of monitoring treatment adherence for more than 10,000 patients simultaneously. These systems allow physicians to track fluid balance, treatment duration, and dialysis efficiency in real time.

Five Recent Developments (2023–2025)

• In 2023, a dialysis equipment manufacturer introduced an automated peritoneal dialysis cycler capable of performing 8 overnight dialysis exchanges, improving treatment efficiency by nearly 18%.
• In 2024, a global dialysis solution producer launched a low-glucose dialysis fluid formulation designed to reduce peritoneal membrane damage by approximately 25% during long-term therapy.
• In 2025, a medical device company developed a portable dialysis cycler weighing 13 kilograms, enabling home dialysis patients to travel while maintaining daily treatment schedules.
• In 2024, a dialysis technology provider introduced remote monitoring software capable of tracking treatment data for more than 5,000 dialysis patients simultaneously.
• In 2023, a renal care manufacturer installed automated dialysis production lines capable of producing more than 1.5 million dialysis solution bags per month, increasing supply capacity for global dialysis clinics.

Report Coverage of Peritoneal Dialysis Market

The Peritoneal Dialysis Market Report provides a comprehensive analysis of global dialysis treatment trends, technology development, and patient adoption patterns across the renal healthcare industry. The Peritoneal Dialysis Market Research Report evaluates clinical data from more than 120 renal care centers and operational insights from over 60 dialysis equipment manufacturers worldwide. The Peritoneal Dialysis Industry Analysis covers product segmentation including dialysis machines, dialysis solutions, and supporting consumables such as catheters and tubing systems. The report analyzes dialysis treatment adoption among more than 380,000 peritoneal dialysis patients globally, providing insights into therapy usage patterns and treatment outcomes.

Regional coverage within the Peritoneal Dialysis Market Insights includes detailed evaluation of healthcare infrastructure across 4 major geographic regions and more than 35 countries with established dialysis programs. The report also examines the expansion of home dialysis programs supporting more than 250,000 patients performing dialysis procedures outside hospital environments. Additionally, the Peritoneal Dialysis Market Forecast section analyzes emerging technologies including automated dialysis cyclers, portable dialysis systems, and remote patient monitoring platforms. The report highlights investment trends influencing Peritoneal Dialysis Market Growth, as well as clinical innovations designed to improve treatment safety, infection control, and long-term patient survival rates.